Literature DB >> 24431393

Evaluating processes underlying the predictive value of baseline erosions for future radiological damage in early rheumatoid arthritis.

Jessica A B van Nies1, Hanna W van Steenbergen1, Annemarie Krabben1, Wouter Stomp2, Tom W J Huizinga1, Monique Reijnierse2, Annette H M van der Helm-van Mil1.   

Abstract

OBJECTIVES: Baseline erosions are characteristic for rheumatoid arthritis (RA) and predictive for a severe disease course. The mechanisms leading to baseline erosions being a strong predictor for radiological progression are unknown. We aimed to increase this understanding by mediation analyses in an observational cohort and a cross-sectional MRI study.
METHODS: 3256 hands and feet radiographs of 653 early RA patients assessed during 7 years of disease were scored using the Sharp-van der Heijde method. Mediation models and multivariate regression analyses were used to explore the association between baseline erosions, other predictors and radiological damage over time. 603 joints (MCP2-5 and MTP1-5) of 67 RA patients underwent 1.5 T MRI at baseline. Data on MRI inflammation were compared with clinical inflammation and baseline radiological erosions.
RESULTS: Patients with baseline erosions had, at any point in time during 7 years, 3.45 times more joint damage than patients without erosions (p<0.001, 95% CI 3.00 to 3.98). Baseline erosions were an independent predictor and not a mediator between symptom duration, systemic or local clinical inflammation (erythrocyte sedimentation rate (ESR), swollen joint count (SJC)) or autoantibodies (anti-citrullinated-peptide antibodies, rheumatoid factor) and radiological damage. Subclinical MRI inflammation was studied in relation to erosions, revealing that 83% of the non-swollen joints with baseline erosions had subclinical MRI inflammation compared with 25% of the non-swollen joints without baseline erosions (OR 15.2 95% CI 3.1 to 102.1). The association between MRI inflammation and baseline erosions was independent of symptom duration, ESR, SJC and autoantibodies.
CONCLUSIONS: Baseline erosions are a predictor for future joint damage, independent of known predictors as time, autoantibodies or clinical measurable inflammation. Subclinical inflammation is suggested as an underlying mechanism. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Early Rheumatoid Arthritis; Magnetic Resonance Imaging; Outcomes Research; Rheumatoid Arthritis

Mesh:

Year:  2014        PMID: 24431393     DOI: 10.1136/annrheumdis-2013-204659

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.

Authors:  M A Quintana-Duque; F Rondon-Herrera; R D Mantilla; E Calvo-Paramo; J J Yunis; A Varela-Nariño; J F Restrepo; A Iglesias-Gamarra
Journal:  Clin Rheumatol       Date:  2016-04-04       Impact factor: 2.980

2.  Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis.

Authors:  Sytske Anne Bergstra; Iris M Markusse; Gülşah Akdemir; H Karel Ronday; K Huub Han; Willem F Lems; Pit J S M Kerstens; Rosaline van den Berg; Robert B M Landewé; Cornelia F Allaart
Journal:  Clin Rheumatol       Date:  2015-12-22       Impact factor: 2.980

3.  Activation of the Peroxisome Proliferator-Activated Receptor γ Coactivator 1β/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis.

Authors:  Jian-Da Ma; Jun Jing; Jun-Wei Wang; Ying-Qian Mo; Qian-Hua Li; Jian-Zi Lin; Le-Feng Chen; Lan Shao; Pierre Miossec; Lie Dai
Journal:  Arthritis Rheumatol       Date:  2019-07-03       Impact factor: 10.995

4.  Do we need to apply a T2T strategy even in ACPA-negative early rheumatoid arthritis? YES.

Authors:  Gianfranco Ferraccioli; Barbara Tolusso; Anna Laura Fedele; Elisa Gremese
Journal:  RMD Open       Date:  2016-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.